Prevention of venous thromboembolism (VTE) remains the number one preventable cause of death in hospitalized patients. The pathogenesis of thrombosis involves the triad of venous stasis, dilatation of the leg veins, and changes in coagulability of the blood. These changes can be modified by the use of intermittent pneumatic compression devices (IPC) and, to a much lesser extent, by graduated compression hose (GCS). Studies have shown the effectiveness of GCS in preventing deep vein thrombosis (DVT) compared to placebo, but there is no evidence that they reduce the incidence of pulmonary emboli (PE). No venographic data are available regarding the efficacy of GCS; however, IPC have shown excellent efficacy in several venographic studies over the past 25 years. Mechanical methods are important to use in situations where the risk of bleeding exists, thereby making the use of anticoagulants hazardous. One of the key uses for mechanical methods is in combination with anticoagulants in patients at the highest risk of developing VTE. Chest consensus guidelines assigns a 2A recommendation for the use of combination prophylaxis in the highest risk patients. Unfortunately, studies to show which type of leg compression device is optimal for DVT prevention are not available, so individual preference, ease of use, and company support are the determining factors at the present time. Finally, compliance using these devices is a major problem, and until systems have been developed to easily monitor and ensure compliance, these methods will enjoy only limited use.
Background
Venous thromboembolism (VTE) is a serious problem that kills 4 to 5 times the number of people annually in the United States than breast cancer or HIV/AIDS. 1 It has been estimated that nearly 300 000 patients die from fatal pulmonary emboli (PE) annually, including one third that present as sudden death. More than 100 000 of these individuals suffer the fatal event after discharge from the hospital. 2 The 1-year mortality rate in the elderly individuals due to PE is thought to be 39% and for deep vein thrombosis (DVT) the rate is estimated to be 21%. 3 Venous thromboembolism has been identified as the number one preventable cause of death in hospitalized patients. 4 This is not just a surgical problem, as 50% to 70% of symptomatic VTE events occur on the medical service and 70% to 80% of fatal PEs occur in nonsurgical patients. 5, 6 
Rationale for Compression
Virchow in 1860 first reported that factors associated with the development of venous thrombosis included hypercoagulability, vascular wall injury, and venous stasis. 7 Studies have demonstrated that when a general or regional anesthetic is administered, significant dilatation of the calf veins occurs due to the loss of leg muscle tone. 8 This study also showed that placing the leg in a dependent position accentuated the degree of venous dilatation. 8 As a result of this dilatation of the leg veins, overdistension can occur and has been shown to result in endothelial cracks that can serve as a nidus for clot formation. The blood comes into contact with the exposed subendothelial collagen and this is beautifully shown in experiments done by Comerota. 9 The flow of blood is slowed under these conditions; metabolic waste products collect and contribute to the patients' hypercoagulability in addition to infections, tumors, or other factors producing changes in the coagulability of the blood. Furthermore, these changes can be modified but certainly not eliminated by the use of elastic compression stockings (graduated compression stockings [GCS]). 10 Intermittent pneumatic leg compression (IPC) devices have been shown to clear blood from the lower extremity and inhibit venous stasis. 11 IPC devices have also been shown to stimulate the fibrinolytic system that may help modulate hypercoagulability seen under these circumstances. 12 
Elastic Compression
Graduated elastic stockings (GCS) have been shown to reduce the cross-sectional area of the legs in humans, which can result in increasing the velocity of blood outflow toward the heart. The increase in velocity has been shown to be proportional to the pressure of the stockings, and studies have revealed that the optimal pressure profile consisted of 18 mm Hg at the ankle and 8 mm Hg in the thigh. 13 Studies in our laboratory in normal volunteers have shown that a stocking with this pressure profile was able to reduce calf venous distension compared to controls with the participants in the reverse Trendelenburg position. We also observed that the stocking group had elevated tissue factor pathway inhibitor levels (TFPI) compared to controls in the Trendelenburg position. 14 Thrombosis prophylaxis using GCS has been demonstrated in a number of trials compared to no prophylaxis. One meta-analysis involving 1800 mostly general surgical patients who were at moderate risk of developing VTE demonstrated a 68% reduction (95% confidence interval, 53%-73%; P < .0001) in the incidence of postoperative DVT using stockings compared to placebo. 15 Another review involving general, gynecologic, orthopedic, and neurosurgical patients also included 9 randomized controlled trials (RCTs). In the treatment group (GCS) of 624 patients, 81 developed DVT (13%) in comparison to the control group of 581 patients, where 154 (27%) had DVT, Peto's odds ratio 0.34 (95% confidence interval 0.25-0.46), favoring treatment with GCS. 16 These large studies involved fibrinogen scans that are subject to certain shortcomings, but the results were sufficiently robust to see GCS used for years in a wide variety of moderate-risk patients. We know of no trials involving stockings as a stand-alone modality for prophylaxis where venography was used as an end point. In addition, there is no evidence that GCS alone reduces the incidence of PE. Finally, the issue of long-leg versus calflength stockings is discussed frequently, and many have the perception that long-leg stockings have a better efficacy for DVT prevention than calf-length GCS. Two trials have been done comparing thigh versus calf-length GCS and the incidence of DVT was 8.7% (9 of 104) and 8.3% (9 of 108), respectively. No definitive conclusions were reached in these 2 studies due to the low DVT rate and small number of patients in the trials. 17, 18 Some investigators have suggested that calflength stockings are easier to fit for most patients and have greater compliance and lower cost, which has increased their popularity. [19] [20] [21] 
Intermittent Pneumatic Compression Devices
The vast majority of devices that are considered mechanical involve a pneumatic compression device supplying air to leg and/or foot chambers that are intermittently inflated with air to a preselected pressure either in a uniform or sequential fashion. A period of cuff emptying follows to allow the leg or foot to refill with blood. There are a variety of devices including single chamber, multiple chamber, calf-length, thigh-length, foot only, and foot and calf. These devices have been designed to work with a compression pressure of 35 to 55 mm Hg, and have compression cycles from 10 to 35 seconds, followed by a deflation period of 1 minute to allow for leg refilling. Recently, a device has appeared that detects the postcompression refill of the leg veins, which has been shown to increase the total volume of blood expelled per hour by 75%. 11 The compression cycle can be as short as 20 seconds, depending on the refilling of blood in the leg. It is theorized that this principle should reduce the overall venous stasis and hence lower the incidence of DVT compared to the other devices. This theory has never been proven and, in fact, there is little evidence to suggest using 1 type of device over another for VTE prevention. Unlike GCS, data are available from the modern era using venography to document the efficacy of IPC in general surgical patients. 22 That data will be further discussed in the section on combined physical and pharmacologic prophylaxis.
IPC alone has been shown to be effective in reducing DVT in a variety of general surgical, urologic, gynecologic, neurosurgical, and orthopedic surgical patients. A large review involving 19 trials using IPC alone as prophylaxis was published in a variety of surgical patients. This analysis involved 2255 patients and showed that IPC significantly reduced the DVT rate from 23.4% (268 of 1147) in the control group to 10.1% (112 of 1108) in the IPC group. This represented a 66% odds reduction (P < .0001). 18 This analysis found no difference between uniform and sequential compression devices. Recently, a large meta-analysis has been published, comprising 15 randomized trials involving 2270 patients with objective testing by imaging techniques. IPC was shown to reduce the DVT incidence by 60% (relative risk 0.40, 95% CI 0.29-0.56; P < .001). 23 Another important effect of IPC is stimulation of fibrinolysis and physiologic inhibitors of coagulation. Investigators have seen an increase in the plasma levels of prostacyclin, 24 tissue plasminogen activator (t-PA), 25 and TFPI. 25 In addition, levels of plasminogen activator inhibitor (PAI-I) are reduced with IPC, 12 and platelet activation was also found to be reduced with this method. 26 Finally, a randomized trial was performed in consecutive patients undergoing total hip replacement to evaluate the effectiveness of sequential intermittent calf and thigh compression for preventing venous thrombosis compared with a control group given no prophylaxis. Deep vein thrombosis confirmed by venography was present in 77 (49%) of 158 control patients compared with 36 (24%) of 152 patients given intermittent compression. Proximal vein thrombosis was present in 42 controls (27%) compared with 22 patients (14%) given intermittent compression. 27 There are limitations to some of these studies because imaging techniques included fibrinogen scanning and impedance plethysmography that in some cases were confirmed with venography. Recent studies have involved duplex scanning in most cases; but in the Turpie trial, the control arm was IPC þ a saline placebo injection. The DVT incidence was 5.3% (22 of 418) in these placebo-treated patients. These venographic results affirmed the low DVT rate with IPC, despite the Caprini 669
fact that 40% of the patients had cancer. The low incidence rate using IPC in general surgery patients coincides with surveys of clinical practice patterns among Fellows of the American College of Surgery that indicate a broad use of these devices as monotherapy following many general surgical operations such as herniorrhaphy, cholycystectomy, hysterectomy, and appendectomy, to name a few. 28 Another limitation with IPC is compliance, which has been reported to vary widely between 29% and 78% 20, 29 and also has been reported to be higher in the ICU setting than on general hospital wards. This author has suggested that the device that detects leg refilling be connected to a timer that would only run when the device was sensing leg refilling. Compliance in minutes per shift could easily be documented using this method. Data to show the relationship between efficacy and length of time the devices are used are lacking and with a timing device this question could be answered. Questions relating to this issue and standardization of the devices are important questions that require further studies.
Combination of Physical and Pharmacologic Methods
The best theoretical approach to thrombosis prophylaxis would be to address all of the Virchow postulates starting before the anticipated confinement or surgery and continuing throughout the entire period of risk. Minimizing venous stasis and dilatation, which would in turn limit endothelial cracking secondary to venous dilatation using IPC, is ideal for preventing DVT. In addition, altering coagulability through the use of anticoagulants combined with the effects of IPC upon fibrinolysis and other coagulation moieties should further reduce DVT incidence.
One large meta-analysis looked at the combined results of 7 RCTs comparing GCS with another method. In the treatment group (GCS þ another method) of 501 patients, 10 (2%) developed DVT whereas in the control group of the 505 patients, 74 (15%) developed DVT, Peto's odds ratio 0.24 (95% confidence interval 0.15, 0.37). A large multicenter trial comparing aspirin to placebo for the prevention of fatal PE following orthopedic surgery showed that aspirin alone did not alter the fatal PE rate; however, a statistically significant reduction in fatalities was observed in the aspirin þ GCS group as well in other groups where combinations of other anticoagulants or mechanical devices with aspirin were used. Overall, 42% of these patients received another modality in addition to aspirin. 30 In another large study (Cochrane analysis), the combination of GCS þ heparin was found to be more effective than heparin alone for the prevention of postoperative DVT. 31 However, 1 study testing the combination of GCS and Fondaparinux compared to Fondaparinux alone found that GCS did not improve the efficacy in patients having total hip replacement. 32 One small study by Lacut in patients with cerebral hemorrhage demonstrated that the incidence of DVT was reduced by approximately 50% using IPC þ GCS compared to GCS alone. 33 A very recent large outcome-blinded, randomized controlled trial, 2518 patients admitted to hospital within 1 week of an acute stroke and who were immobile were enrolled from 64 centers in the United Kingdom, Italy, and Australia. Patients received routine care plus either thigh-length GCS (n ¼ 1256) or no GCS (n ¼ 1262). Doppler ultrasound of both the legs was done at 7 to 10 days and, repeated 25 to 30 days after enrollment. Deep vein thrombosis occurred in 126 (10Á0%) patients allocated to thigh-length GCS and in 133 (10Á5%) allocated to avoid GCS, resulting in a nonsignificant absolute reduction in risk of 0Á5% (95% CI -1.9%-2.9%). Skin breaks, ulcers, blisters, and skin necrosis were more common in those wearing stockings. 34 Based on these and several other studies, GCS are ineffective in the prevention of DVT in patients with Stroke.
The majority of investigations regarding combined modalities involve IPC combined with various anticoagulants. Maxwell Borow was a pioneer vascular surgeon who provided some important early data regarding a number of aspects regarding thrombosis prophylaxis in surgical patients. At that time, the standard objective end point was fibrinogen scanning, which had a number of problems regarding sensitivity and specificity, and many investigators including Borow confirmed positive scan results with venography. He was able to show in a group of 328 patients that the combination of 1 of 3 anticoagulants combined with IPC resulted in a 1.5% incidence of DVT compared to a 26.8% incidence in the control group. 35 In another large series involving 2551 patients undergoing coronary artery bypass surgery over a 10-year period, the incidence of clinically evident, imaging-proven PE was studied. Patients received either 5000 units of unfractionated heparin (UFH) twice daily alone or in combination with long-leg sequential IPC. Of the heparin-treated patients, 4% has a PE while the incidence in the combined group was 1.5%. 36 Another study involved 1803 orthopedic patients who were prospectively randomized to receive either low-molecular-weight heparin (LMWH) alone or in combination with IPC. In all, 15 patients (1.7%) were diagnosed with a DVT, including 3 symptomatic thromboses. In the combined group, 4 patients (0.4%) were diagnosed with DVT, including one symptomatic thrombosis. The difference between the groups was significant (P ¼ .007). In the combined group, no DVTs were found in patients who received more than 6 hours of IPC daily. 37 Recently, the largest single study involving pneumatic compression with a venographic end point was completed using IPC alone or IPC plus Fondaparinux in a population of 1309 general surgical patients. The results showed a 1.7% DVT rate in the combined group compared to 5.3% using IPC alone. Several important conclusions can be reached from these results, including the remarkable fact that the combined DVT rate was almost exactly the same as found by Borow, nearly 25 years ago. In addition, over 94% of the patients receiving IPC alone had no venographic evidence of DVT, reaffirming that IPC alone also prevented VTE. No differences in the clinical incidence of VTE were seen between the groups. 22 In a recent Cochrane review compared to compression alone, the use of combined modalities significantly reduced the incidence of both symptomatic PE (from about 3% to 1%) and
DVT (from about 4% to 1%). When compared with pharmacological prophylaxis alone, the use of combined modalities significantly reduced the incidence of DVT (from 4.21% to 0.65%, but the included studies were underpowered with regard to PE. The comparison of compression and pharmacological prophylaxis together with a combination of compression and aspirin showed an insignificant reduction in PE and DVT in favor of the former group. Repeat analysis restricted to the RCTs confirmed the above findings. 38 A number of smaller studies exist that involve combination prophylaxis involving IPC or foot pumps but they are small in size and/or lack venographic end points in orthopedic surgery patients. [39] [40] [41] Unfortunately, the accuracy of duplex ultrasonography as an end point in orthopedic surgery has been questioned. 5 A substudy of 2 similarly designed, phase IIb trials of a novel oral anticoagulant for the prevention of VTE after elective hip or knee arthroplasty was undertaken to validate compression ultrasonography against venography. Patients received study drugs until mandatory bilateral venography was performed 7 + 2 days after surgery. Compression ultrasonography (CCUS) was performed within 24 hours after venography and 2 independent readers adjudicated venograms and sonograms centrally at different sites. A total of 1104 matching pairs of evaluable venograms and sonograms were obtained from the participants of the 2 trials (n ¼ 1435). The observed frequency of any DVT was 18.9% with venography and 11.5% with CCUS. Sensitivity of CCUS compared with venography was 31.1% for any DVT (95% confidence interval 23.4-38.9), 21.0% (2.7-39.4) for proximal DVT, and 30.8% (23.1-38.6) for distal DVT. The figures for specificity were 93.0% (91.0-95.1), 98.7% (98.0-99.5), and 93.3% (91.5-95.3), respectively. The authors state that ''based on these results, centrally adjudicated CCUS will be unable to replace venography for DVT screening early after major orthopedic surgery in studies evaluating anticoagulant drugs.'' 42
Current CHEST Recommendations For Mechanical Methods
The eighth American College of Chest Physicians (ACCP) Conference on Antithrombotic and Thrombolytic therapy (CHEST) guidelines include a recommendation that the primary uses for mechanical methods of thromboprophylaxis are as adjuncts to more effective measures and in patients at high risk of bleeding. 43 The author's further comment that physical methods have not been shown to reduce the rates of PE or death, and most devices on the market have not undergone rigorous testing. They are less effective than pharmacologic thromboprophylaxis, and they are often not fitted or used properly. Their conclusion regarding efficacy is somewhat surprising, given the venographic results of the Turpie trial as well as the Urbankova meta-analysis. 32, 44 Nevertheless, CHEST points out that there is no standardization of these devices by the manufacturers, and no need to show efficacy as long as they are shown to be safe. In addition, very scant details are available in RCTs involving compression. 43 Another problem is the issue of compliance that has been shown to be poor by Comerota. 45 No attempt was made by any of the companies to provide timing devices or other electronic measures to tract compliance. The relationship between efficacy and time of daily use is unknown and is a factor that limits their use.
Evidence-Based Guidelines vs. Clinical Practice Guidelines
Unfortunately, the patients evaluated in randomized clinical trials are often not representative of patients seen in clinical practice. Trial patients with multiple comorbidities, a past history of VTE, cancer, or congestive heart failure, to name a few, are not routinely included in these trials. As a result, individual decisions for a given patient may differ from the group recommendations in the Chest consensus document. The clinician must combine the knowledge of literature with logic, emotion, and clinical experience to tailor the best prophylaxis for an individual patient. The authors of CHEST include this statement addressing this clinical need.
Conclusions
The physical methods including IPC and GCS are important modalities in the armamentarium of the clinician. The reader should not confuse the static and pneumatic modalities, as they are certainly not interchangeable. Graduated compression stockings have been shown to limit venous distension in patients, particularly when the legs are dependent. 14 Multiple hemodynamic studies have been conducted testing IPC, and there is no comparison regarding the large blood volumes moved by the pneumatic devices that are not seen with the stockings. 11 Prevention of venous thrombosis using GCS has been demonstrated in earlier studies compared to placebo; however, these stockings have only a weak thromboprophylactic effect compared to IPC and traditional pharmacologic modalities. 16 This author is not aware of any venographic data that show efficacy using GCS, whereas the large recent RCT involving pneumatic compression included a venographic end point. 22 Unfortunately, the current CHEST guidelines have not pointed this out and in various sections suggest the use of these modalities interchangeably. 43 One example would be a patient having a total hip operation with a high bleeding risk. CHEST guidelines would allow the use of GCS and or IPC for postoperative prophylaxis. The efficacy of GCS alone is very weak compared to the properly fitted and used leg IPC devices. There is little evidence and no venographic evidence to suggest the use of GCS alone. In fact the large stroke trial showed no benefit compared to standard care alone.
Foot pump compression has not been tested on the scale performed for IPC and limited venographic data in small series with these modalities are available. 40 Finally, studies to identify the optimal IPC device and the type of compression for the prevention of VTE are not available and, as a result, the choice of leg compression devices for DVT prevention is a matter of preference and ease of use.
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We feel that one important consideration for GCS and IPC is their use before, during, and immediately after surgery to limit venous stasis and endothelial damage from venous overdistension that can occur with calf muscle paralysis during intubation or spinal anesthetics. These devices can also protect the patient if the surgeon, due to the risk of bleeding, delays the initiation of postoperative anticoagulants.
There is good evidence that the use of combined modalities employing anticoagulants and especially IPC increases efficacy without increased complications in the highest risk surgical patients. CHEST does assign a 2A rating for the combination of physical and pharmacologic modalities in these patients. 43 Finally, IPC devices must be functioning properly and must be correctly applied to the patient. The Achilles' heel of these modalities is lack of effective methods to ensure compliance. Until better strategies are developed to ensure compliance, the widespread use of these devices will remain limited.
